Home › Funds › FRED ALGER MANAGEMENT, LLC › DNTH

FRED ALGER MANAGEMENT, LLC position in DNTH

DIANTHUS THERAPEUTICS INC COM · Health Care

FRED ALGER MANAGEMENT, LLC reported holding 1,302,493 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$127.0M, representing 0.42% of its reported portfolio and ranking #34 among its reported holdings. FRED ALGER MANAGEMENT, LLC has disclosed DNTH holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)1.30M sh
Reported value held$126.97M
Portfolio Weight0.42%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FRED ALGER MANAGEMENT, LLC's DNTH position evolved

FRED ALGER MANAGEMENT, LLC first disclosed a stake in DNTH in Q4 2023 at 40,841 shares (US$425K). The position peaked in Q2 2026 at 1,302,493 shares, worth US$127.0M. Across 8 filings, FRED ALGER MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,302,493 shares valued at US$127.0M — an increase of 140,570 shares quarter over quarter.. Notable position changes include a 83% trim in Q2 2024 (shares rose 6% over the following quarter), a 52% increase in Q3 2024 (shares fell 20% over the following quarter), a 3373% increase in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 40.84K $424.75K New
Q1 2024 36.37K $1.09M Reduce
Q2 2024 6.32K $163.48K Reduce
Q3 2024 9.63K $263.75K Add
Q3 2025 45.30K $1.78M New
Q4 2025 33.46K $1.38M Reduce
Q1 2026 1.16M $97.51M Add
Q2 2026 1.30M $126.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 72 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has FRED ALGER MANAGEMENT, LLC held DNTH?

FRED ALGER MANAGEMENT, LLC has disclosed DNTH holdings in 8 of the last 11 reported quarters, going back to Q4 2023.

What is FRED ALGER MANAGEMENT, LLC's current position in DNTH?

As of Q2 2026, FRED ALGER MANAGEMENT, LLC holds 1.30M shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $126.97M, representing 0.42% of its reported portfolio and ranking #34.

Has FRED ALGER MANAGEMENT, LLC been buying or selling DNTH?

In the latest 13F filing (Q2 2026), FRED ALGER MANAGEMENT, LLC increased its position in DNTH. The position peaked in Q2 2026 at 1.30M shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.